Pancreatic cancer finally better known!
Researchers at the Jules Bordet Institute and the Erasmus Hospital identify five subtypes of pancreatic cancer
Researchers at the Jules Bordet Institute and the Erasmus Hospital identify five subtypes of pancreatic cancer
Live life to the full in 2019!
Summary 3 - Edito 4 - Prise en charge thérapeutique du cancer du sein : de la mutilation à la guérison. (Pr Jean-Marie Nogaret)
30/03/2019 :Le traitement du cancer bronchique : quels progrès en pratique en 20 ans?
Watch the video and discover the major project for the new Jules Bordet Institute .....
Visits to patients are allowed subject to certain conditions. Persons accompanying out-patients are allowed (consultations and technical medical procedures)
What exactly do we mean by personalised breast cancer screening?
The Jules Bordet Institute supports the Movember campaign
All members of the Jules Bordet Institute and the care staff in particular need support, understanding and goodwill during this period of crisis.
The Jules Bordet Institute is participating in Nutrition Day 2020.
A new study makes it possible to select patients who will enjoy long-term benefits from surgery
May 2021 exude calm, solidarity and goodwill !
Metastatic breast cancers : Characterising the profile of metastases for improved treatment
Super Tombola for cancer research - Lottery : 04/07/2017
Press : Viruses hijack cancer genes to cause leukemia (A team of Institut Jules Bordet - University of Brussels and GIGA-University of Liège)
On the occasion of sarcoma awareness month, the Jules Bordet Institute is taking a look at the specific characteristics of these rare tumours that affect nearly 600 people a year in Belgium.
Lymphoma is a cancer of the immune system with around 1,250 new cases diagnosed every year in Belgium
Subsides 2022 - La radiothéranostique, les traitements de demain qui soignent déjà aujourd’hui (François Daubresse)
Today more than ever, the Hôpital Universitaire de Bruxelles (H.U.B) is supporting the fight against breast cancer
This acquisition will enrich the department's digital pathology platform